Highlights Peptron, Inc.

Equities

A087010

KR7087010005

Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 2026-02-13			5-day change	1st Jan Change
244,000.00 ^KRW	-1.81%		-1.41%	-3.94%

24-10-08	Peptron Signs Deal with Eli Lilly for Peptide Drug Research	MT
23-12-21	Invex Therapeutics, Peptron End Collaboration, Manufacturing Deal	MT

Highlights

24-10-08	Peptron Signs Deal with Eli Lilly for Peptide Drug Research	MT
23-12-21	Invex Therapeutics, Peptron End Collaboration, Manufacturing Deal	MT
23-10-04	Tranche Update on Peptron, Inc.'s Equity Buyback Plan announced on April 5, 2023.	CI
23-10-04	Tranche Update on Peptron, Inc.'s Equity Buyback Plan announced on April 5, 2023.	CI
23-10-03	Peptron, Inc.'s Equity Buyback announced on April 5, 2023, has expired with 73,961 shares, representing 0.36% for KRW 891.08 million.	CI
23-07-07	Tranche Update on Peptron, Inc.'s Equity Buyback Plan announced on April 5, 2023.	CI
23-04-04	Peptron, Inc. authorizes a Buyback Plan.	CI
22-11-27	Peptron, Inc. Establishes Bioequivalence of PT105	CI
21-09-26	Invex Therapeutics Ltd Announces the Signing of a Long Term Collaboration and Manufacturing Agreement with Peptron, Inc	CI
21-04-16	Qilu Pharmaceutical and Peptron Sign License Agreement for Anti-MUC1 ADC	CI
18-07-16	Peptron, Inc. Announces Published Data Showing a New Sustained-Release Exendin-4 Formulation Prevents Neurodegeneration in a Parkinson's Disease Model	CI
15-07-17	Peptron, Inc. has completed an IPO in the amount of KRW 13.04 billion.	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Filters

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

Unlock them now!